Tilray (NASDAQ:TLRY) Announces Earnings Results

Tilray (NASDAQ:TLRYGet Free Report) announced its quarterly earnings data on Friday. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.07), Zacks reports. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business had revenue of $210.90 million during the quarter, compared to analysts’ expectations of $216.34 million. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. Tilray updated its FY 2025 guidance to EPS.

Tilray Trading Down 10.2 %

Shares of TLRY stock opened at $1.23 on Friday. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $1.11 billion, a price-to-earnings ratio of -4.56 and a beta of 2.08. Tilray has a 12-month low of $1.14 and a 12-month high of $2.97. The stock’s 50-day moving average price is $1.36 and its 200-day moving average price is $1.62.

Insider Activity at Tilray

In other Tilray news, CFO Carl A. Merton acquired 26,000 shares of the stock in a transaction on Friday, November 15th. The stock was acquired at an average price of $1.36 per share, for a total transaction of $35,360.00. Following the completion of the transaction, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.87% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Separately, Roth Mkm lowered their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a report on Friday, October 11th.

Get Our Latest Research Report on TLRY

Tilray Company Profile

(Get Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

See Also

Earnings History for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.